Results 131 to 140 of about 5,730 (206)

Interference of small compounds and Mg²⁺ with dsRNA-binding fluorophores compromises the identification of SARS-CoV-2 RdRp inhibitors. [PDF]

Sci Rep
Llanos S, Di Geronimo B, Casajús E, Blanco-Romero E, Fernández-Leiro R, Méndez J.   +5 more
europepmc   +1 more source

Determinant Factors of the Direct Medical Costs Associated with Genotype 1 Hepatitis C Infection in Treatment-Experienced Patients [PDF]

, 2015

core   +1 more source

Directly acting antivirals improve insulin resistance in nondiabetic patients with hepatitis C: a systematic review and meta-analysis. [PDF]

Ann Med Surg (Lond)
Lamichhane P, Makhlouf SSK, Saleem K, Senliya D, Wajid A, Khanal K, Agrawal A.   +6 more
europepmc   +1 more source

Hepatitis C Virus Resistance-Associated Substitutions in Mexico. [PDF]

Viruses
Jose-Abrego A, Laguna-Meraz S, Roman S, Mariscal-Martinez IM, Panduro A.   +4 more
europepmc   +1 more source

Correction: Liu et al. The Discovery of Novel Agents against Staphylococcus aureus by Targeting Sortase A: A Combination of Virtual Screening and Experimental Validation. Pharmaceuticals 2024, 17, 58. [PDF]

Pharmaceuticals (Basel)
Liu K, Tong J, Liu X, Liang D, Ren F, Jiang N, Hao Z, Li S, Wang Q.   +8 more
europepmc   +1 more source

PIN108 Assessing Knowledge and Attitude about ebola in the US: a Cross Sectional Survey [PDF]

, 2015
Jamal, A., Startsman, K., Guy, J., Pierce, R., Ahmad, A., Chang, J., Kidd, R., Johnson, M., Patel, I.   +8 more
core   +1 more source

Predictive factors for 24 weeks sustained virologic response (SVR24) and viral relapse in patients treated with simeprevir plus peginterferon and ribavirin [PDF]

core   +1 more source

Safety, tolerability, and pharmacokinetics of faldaprevir after single increasing doses in healthy subjects. [PDF]

Front Pharmacol
Yong CL, Sennewald R, Nehmiz G, Quinson AM, Huang F.   +4 more
europepmc   +1 more source

Development of an inhibitory TTC7B selective nanobody that blocks EFR3 recruitment of PI4KA. [PDF]

J Biol Chem
Suresh S, Shaw AL, Akintola DK, Lunke M, Doerr S, Rohilla P, Balla T, Yip CK, Hansen SD, Cobb JA, Burke JE.   +10 more
europepmc   +1 more source

Outcomes of Direct-Acting Antivirals Versus Interferon-Based Therapy in Chronic Hepatitis C Infection.

Cureus
Chowdhury R, Rashid W, Singh T, Rehman A, Daterdiwala NF, Mkosi V, Limbu B, Bukhari SA, Ramadhan A, Dabas MM, Shehryar A, Khan R.   +11 more
europepmc   +1 more source